Mesothelioma treatment and research update

San Pedro, CA–August 25, 2007

A potential tumor growth inhibitor and anti-angiogenesis agent for pleural mesothelioma,
Phase II testing of sunitinib

Mesothelioma and lung cancer risk after cessation of asbestos exposure. A cohort study of Italian asbestos cement workers

Metabolic imaging has the potential to improve the care of patients receiving chemotherapy for mesothelioma


Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: